Literature DB >> 4322309

The rationale of alternate-day corticosteroid therapy.

M E Jacobson.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 4322309     DOI: 10.1080/00325481.1971.11696519

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


× No keyword cloud information.
  1 in total

1.  Intermittent long-term adrenocorticosteroid treatment of myasthenia gravis.

Authors:  N Wakata; Y Kawamura; M Kobayashi; Y Araki; M Kinoshita
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.